FDA Clears Neuromodulation Device for Acute Migraine Pain – MedScape

Read article - Quotes Stewart Tepper, professor of neurology, in an article about the U.S. Food and Drug Administration's clearance of the first noninvasive multichannel brain neuromodulation system to treat acute migraine pain. "Patients will now have access to a highly effective, easy-to-use, non-invasive, and drug free therapeutic option that will help them regain control of their lives," said Teppe